AMRX 外匯新聞
Amneal Pharma Says FDA Approves Lisdexamfetamine Dimesylate Capsules
Amneal Pharmaceuticals, Inc. (AMRX) announced Wednesday it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration for lisdexamfetamine dimesylate capsules, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg.
RTTNews
|
537天前
Amneal Pharma Says FDA Accepts For Review ANDA For Naloxone Hydrochloride Nasal Spray
Essential medicines company Amneal Pharmaceuticals, Inc. (AMRX) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New Drug Application (ANDA) for naloxone hydrochloride nasal spray, USP, 4mg, which is the generic version of Narcan and is used in the treatment of a known or suspected opioid overdose emergency.
RTTNews
|
725天前
